• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿昔洛韦局部给药有机凝胶的制剂、优化与评价

Formulation, Optimization and Evaluation of Organogel for Topical Delivery of Acyclovir.

作者信息

Bonde Smita, Mavani Nisarg, Bonde Chandrakant

机构信息

SVKM's NMIMS, School of Pharmacy and Technology Management, Shirpur Campus, Maharashtra, India.

出版信息

Curr Drug Deliv. 2018;15(3):397-405. doi: 10.2174/1567201814666171013150938.

DOI:10.2174/1567201814666171013150938
PMID:29034838
Abstract

BACKGROUND

The conventional acyclovir topical therapy has a low efficacy, due to the lack of penetration of a sufficient amount of drug to the target site.

OBJECTIVE

The aim of this work was to formulate and optimize organogel containing acyclovir to enhance the penetration and retention time of acyclovir in the basal epidermis, site of Herpes simplex virus infections.

METHODS

Microemulsion based organogel containing acyclovir was developed using the combination of surfactants, polar and nonpolar solvents. To investigate the microemulsion and gelling region, titration was carried out and pseudoternary phase diagram was constructed. The formulation was optimized by using 3-factor, 3-level, Box-Behnken design. Response surface plots were constructed for various response variables, viz. % drug permeation, viscosity and spreadability. The optimized formulation was searched utilizing overlay plots and desirability of the response. The optimized formulation was further characterized for microscopy, pH, ex-vivo permeation etc. Ex-vivo skin permeation showed first order drug diffusion through the skin and was found being stable upto 8 hrs.

RESULTS

In case of developed organogel formulation, significantly higher amount of acyclovir was observed to be retained in the skin, as compared to retention observed with the conventional cream.

CONCLUSION

The results show that the ACV organogel penetrates into the skin and form the reservoir that can slowly release the drug for a longer period and may control viral growth more effectively.

摘要

背景

传统的阿昔洛韦局部治疗疗效较低,原因是缺乏足够量的药物渗透到靶部位。

目的

本研究旨在制备并优化含阿昔洛韦的有机凝胶,以提高阿昔洛韦在单纯疱疹病毒感染部位——基底表皮中的渗透及滞留时间。

方法

采用表面活性剂、极性和非极性溶剂组合,开发了含阿昔洛韦的基于微乳液的有机凝胶。通过滴定法研究微乳液和凝胶化区域,并构建伪三元相图。采用三因素三水平的Box-Behnken设计对制剂进行优化。针对不同的响应变量,即药物渗透百分比、粘度和铺展性,构建响应面图。利用叠加图和响应的合意性搜索优化制剂。对优化后的制剂进行显微镜检查、pH值、体外渗透等进一步表征。体外皮肤渗透显示药物通过皮肤呈一级扩散,且在8小时内保持稳定。

结果

与传统乳膏相比,所开发的有机凝胶制剂在皮肤中的阿昔洛韦滞留量显著更高。

结论

结果表明,阿昔洛韦有机凝胶可渗透到皮肤中并形成储库,能够长时间缓慢释放药物,可能更有效地控制病毒生长。

相似文献

1
Formulation, Optimization and Evaluation of Organogel for Topical Delivery of Acyclovir.阿昔洛韦局部给药有机凝胶的制剂、优化与评价
Curr Drug Deliv. 2018;15(3):397-405. doi: 10.2174/1567201814666171013150938.
2
Topical delivery of acyclovir and ketoconazole.阿昔洛韦和酮康唑的局部给药。
Drug Deliv. 2016;23(2):631-41. doi: 10.3109/10717544.2014.933283. Epub 2014 Jul 9.
3
Acyclovir-loaded sorbitan esters-based organogel: development and rheological characterization.基于山梨醇酯的阿昔洛韦负载型有机凝胶:制备与流变学表征
Artif Cells Nanomed Biotechnol. 2017 May;45(3):551-559. doi: 10.3109/21691401.2016.1161639. Epub 2016 Mar 26.
4
Assessment of correlation between skin target site free drug concentration and the in vivo topical antiviral efficacy in hairless mice for (E)-5-(2-bromovinyl)-2'-deoxyuridine and acyclovir formulations.评估无毛小鼠中(E)-5-(2-溴乙烯基)-2'-脱氧尿苷和阿昔洛韦制剂的皮肤靶位点游离药物浓度与体内局部抗病毒疗效之间的相关性。
J Pharm Sci. 1998 Aug;87(8):917-21. doi: 10.1021/js980052a.
5
Utilization of nanotechnology to enhance percutaneous absorption of acyclovir in the treatment of herpes simplex viral infections.利用纳米技术提高阿昔洛韦的经皮吸收用于单纯疱疹病毒感染的治疗。
Int J Nanomedicine. 2015 Jun 15;10:3973-85. doi: 10.2147/IJN.S83962. eCollection 2015.
6
Evaluation of the in vitro skin permeation of antiviral drugs from penciclovir 1% cream and acyclovir 5% cream used to treat herpes simplex virus infection.对用于治疗单纯疱疹病毒感染的1%喷昔洛韦乳膏和5%阿昔洛韦乳膏中抗病毒药物的体外皮肤渗透情况进行评估。
BMC Dermatol. 2009 Apr 2;9:3. doi: 10.1186/1471-5945-9-3.
7
Topical application of acyclovir-loaded microparticles: quantification of the drug in porcine skin layers.负载阿昔洛韦微粒的局部应用:猪皮肤层中药物的定量分析。
J Control Release. 2001 Jul 10;75(1-2):191-7. doi: 10.1016/s0168-3659(01)00395-9.
8
Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections.开发用于治疗皮肤疱疹感染的新型阿昔洛韦微乳基局部用制剂。
AAPS PharmSciTech. 2009;10(2):559-65. doi: 10.1208/s12249-009-9242-1.
9
Enhanced acyclovir delivery using w/o type microemulsion: preclinical assessment of antiviral activity using murine model of zosteriform cutaneous HSV-1 infection.采用 w/o 型微乳增强阿昔洛韦传递:利用带状疱疹样皮肤单纯疱疹病毒 1 感染的鼠模型评估抗病毒活性的临床前研究。
Artif Cells Nanomed Biotechnol. 2018 Mar;46(2):346-354. doi: 10.1080/21691401.2017.1313262. Epub 2017 Apr 12.
10
Dual sustained release delivery system for multiple route therapy of an antiviral drug.用于抗病毒药物多途径治疗的双持续释放给药系统。
Drug Deliv. 2014 Jun;21(4):276-92. doi: 10.3109/10717544.2013.839368. Epub 2013 Oct 17.